Allyl (3-(2-nitrophenylsulfonamido)propyl)carbamate

Catalog No.: 
ACIXFR808
CAS No.: 
312283-45-7
Molecular Formula: 
C13H17N3O6S
Molecular Weight: 
343.36
Allyl (3-(2-nitrophenylsulfonamido)propyl)carbamate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$449.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameAllyl (3-(2-nitrophenylsulfonamido)propyl)carbamate
IUPAC Nameallyl (3-((2-nitrophenyl)sulfonamido)propyl)carbamate
MDL No.MFCD08276406
Molecular FormulaC13H17N3O6S
Molecular Weight343.36
SMILESO=C(OCC=C)NCCCNS(=O)(C1=CC=CC=C1[N+]([O-])=O)=O
InChI KeyINKIDQWOEVNHHA-UHFFFAOYSA-N
SynonymAllyl (3-((2-nitrophenyl)sulfonamido)propyl)carbamate | T72276 | DTXSID20440904 | [3-(2-Nitrobenzenesulfonamido)propyl]carbamic Acid Allyl Ester | AKOS025295125 | CS-0361180 | SCHEMBL9923589 | N0717 | MFCD08276406 | Allyl [3-(2-Nitrobenzenesulfonamido)pro
CAS No.312283-45-7
PubChem CID10497545

Synthetic Route by SureRoute

1. ACIXFR808 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACLQIN723 route compound structure diagram
    ACLQIN7231049721-72-3In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACIXFR808 route product structure diagram
    ACIXFR808312283-45-7
Inquiry

2. ACIXFR808 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACIXFR808 route product structure diagram
    ACIXFR808312283-45-7
Inquiry

3. ACIXFR808 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACIXFR808 route product structure diagram
    ACIXFR808312283-45-7
Inquiry

Comments (0)